Copyright © 2023 O'Connor, Acciani and Levy. All rights reserved.
O’Connor, Acciani & Levy is no longer accepting cases for Benicar.
In the past two years, the U.S. Food and Drug Administration (FDA) has approved label changes for Benicar after it was revealed that the drug could cause intestinal problems and increase the risk of cardiovascular problems in diabetic patients.
Have you or someone the you love suffered from a gastrointestinal condition or cardiovascular problem as a result of taking this dangerous drug?
The dangerous drugs attorneys at the law offices of O’Connor, Acciani & Levy are currently accepting inquiries from users of Benicar and can help you determine if you are eligible to file a lawsuit.
Contact our Cincinnati Benicar lawyers today to schedule a free, confidential consultation. We charge no upfront costs or legal fees unless you recover compensation.
Benicar, or olmesartan, is in a group of drugs called angiotensin II receptor antagonists. These drugs are used to treat blood pressure by keeping blood vessels from narrowing.
Since the drug first entered the market, a number of studies have identified links to dangerous side effects, including sprue-like enteropathy, an intestinal condition that mimics the symptoms of celiac disease.
The FDA has identified 23 reports in the FDA Adverse Event Reporting System that included symptoms that could suggest sprue-like enteropathy. These symptoms receded when patients stopped taking olmesartan.
In 2012, the Mayo Clinic uncovered a link between olmesartan and enteropathy after examining symptoms that were similar to celiac disease among 22 patients taking the medication. During that study, internal biopsies showed villous atrophy and mucosal inflammation. A gluten free lifestyle did not help patients. However, when olmesartan was discontinued, their symptoms improved.
In 2013, the FDA published a drug safety communication stating that Benicar and Benicar HCT could cause sprue-like enteropathy. It then required changes to the drug’s label to include this risk.
Although the FDA believes that taking Benicar is still safe, it has alerted consumers that they should be aware of any potential side effects associated with the drug. The drug’s manufacturer had previously failed to warn of the side effects.
Some other common side effects linked to Benicar and symptoms associated with sprue-like enteropathy include:
Patients need to also be mindful of cardiovascular problems such as high blood pressure, chest pain, and shortness of breath.
If you have experienced any of these side effects after taking Benicar, you may be entitled to compensation through a lawsuit. Contact our Cincinnati lawyers today for help determining if a Benicar lawsuit is right for you.
Because many of these label changes came years after Benicar was already on the market, many victims were not aware that it was their medication that led to these medical complications.
Victims of Benicar may be entitled to file a Benicar lawsuit against Daiichi Sankyo, the drug’s manufacturer, for failing to warn consumers about these dangerous side effects.
At the law offices of O’Connor, Acciani & Levy, we are dedicated to helping victims of dangerous drugs obtain the compensation they deserve. Suffering because of a company’s carelessness is something no one should ever have to endure. Speak with our Cincinnati Benicar lawyers today.